1-5 of 5
Mark L. Bonyhadi, PhD
Close
Sort by
Journal Articles

Combined Cytoreduction and Infusion of Anti-CD3/Anti-CD28 Bead-Activated T Cells Prevent Diabetes in NOD Mice.

Ronald J. Berenson, MD, Sarah A. Long, PhD, Mark L. Bonyhadi, PhD
Journal: Blood
Blood (2005) 106 (11): 3036.
https://doi.org/10.1182/blood.V106.11.3036.3036
Published: 2005
Journal Articles

Anti-CD3/Anti-CD28 Bead-Activated T Cells Facilitate Engraftment of Murine Histoincompatible Allogeneic Transplants after Low-Dose Radiation.

Ronald J. Berenson, MD, Julie K. Ritchey, PhD, Mark L. Bonyhadi, PhD, John F. DiPersio, MD
Journal: Blood
Blood (2005) 106 (11): 5221.
https://doi.org/10.1182/blood.V106.11.5221.5221
Published: 2005
Journal Articles

Restoring a Normal T Cell Receptor Repertoire Using the Xcellerate™ Technology: A Potential Therapeutic Strategy for Patients with Hematological Disorders and Autoimmune Diseases.

Alice Long, PhD, Jahan Khalili, Joy Lawrence, Ronald J. Berenson, MD, Mark L. Bonyhadi, PhD
Journal: Blood
Blood (2004) 104 (11): 3853.
https://doi.org/10.1182/blood.V104.11.3853.3853
Published: 2004
Journal Articles

Biological Characteristics of T Cells from CD4 Idiopathic Lymphocytopenia Patients Activated and Expanded Using Xcellerate™ Technology.

Joy Lawrence, Mark L. Bonyhadi, PhD, Charlotte Cunningham-Rundles, MDPhD, Ronald J. Berenson, MD, Alice Long, PhD
Journal: Blood
Blood (2004) 104 (11): 3834.
https://doi.org/10.1182/blood.V104.11.3834.3834
Published: 2004
Journal Articles

In Vivo Suicide Gene Therapy of Human T Lymphocytes To Prevent Graft Versus Host Disease in a Murine Xenograft Model.

Bruno Nervi, MD, Michael Rettig, PhD, Julie Ritchey, Jon Walker, Gerhard Bauer, Philip Herrbrich, Mark L. Bonyhadi, PhD, Jan A. Nolta, PhD, John F. DiPersio, MD/PhD
Journal: Blood
Blood (2004) 104 (11): 4979.
https://doi.org/10.1182/blood.V104.11.4979.4979
Published: 2004